These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36339419)

  • 1. Clinical characteristics and the influence of rs1800470 in patients with Camurati-Engelmann disease.
    Liang H; Jiajue R; Qi W; Liu W; Chi Y; Jiang Y; Wang O; Li M; Xing X; Xia W
    Front Endocrinol (Lausanne); 2022; 13():1041061. PubMed ID: 36339419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and identification of a novel TGFB1 variant in three unrelated Chinese families with Camurati-Engelmann disease.
    Tao XH; Yang XG; Wang ZY; Xu Y; Lin XY; Xu T; Zhang ZL; Yue H
    Mol Genet Genomic Med; 2022 May; 10(5):e1922. PubMed ID: 35315241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ENU-induced p.C225S missense mutation in the mouse Tgfb1 gene does not cause Camurati-Engelmann disease-like skeletal phenotypes.
    Ichimura S; Sasaki S; Murata T; Fukumura R; Gondo Y; Ikegawa S; Furuichi T
    Exp Anim; 2017 May; 66(2):137-144. PubMed ID: 27928112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camurati-Engelmann disease with obesity in a newly identified family carrying a missense p.Arg156Cys mutation in the TGFB1 gene.
    Collet C; Laplanche JL; de Vernejoul MC
    Am J Med Genet A; 2013 Aug; 161A(8):2074-7. PubMed ID: 23824952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.
    Whyte MP; Totty WG; Novack DV; Zhang X; Wenkert D; Mumm S
    J Bone Miner Res; 2011 May; 26(5):920-33. PubMed ID: 21541994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of Bone Density, Microarchitecture, and Strength in Patients with Camurati-Engelmann Disease: Assessed by HR-pQCT.
    Li Q; Zhao Z; Wu B; Pang Q; Cui L; Zhang L; Jiang Y; Wang O; Li M; Xing X; Hu Y; Yu W; Meng X; Jiajue R; Xia W
    J Bone Miner Res; 2022 Jan; 37(1):78-86. PubMed ID: 34490910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.
    Park SJ; Yoon CS; Park HW; Choi JR; Chung JS; Lee KA
    J Korean Med Sci; 2009 Aug; 24(4):737-40. PubMed ID: 19654961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.
    Janssens K; Vanhoenacker F; Bonduelle M; Verbruggen L; Van Maldergem L; Ralston S; Guañabens N; Migone N; Wientroub S; Divizia MT; Bergmann C; Bennett C; Simsek S; Melançon S; Cundy T; Van Hul W
    J Med Genet; 2006 Jan; 43(1):1-11. PubMed ID: 15894597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and treatment outcomes in Camurati-Engelmann disease: A case series.
    Kim YM; Kang E; Choi JH; Kim GH; Yoo HW; Lee BH
    Medicine (Baltimore); 2018 Apr; 97(14):e0309. PubMed ID: 29620655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthopedic Manifestations of Type I Camurati-Engelmann Disease.
    Yuldashev AJ; Shin CH; Kim YS; Jang WY; Park MS; Chae JH; Yoo WJ; Choi IH; Kim OH; Cho TJ
    Clin Orthop Surg; 2017 Mar; 9(1):109-115. PubMed ID: 28261436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.
    Cui L; Li Q; Guan W; Yu W; Li X; Xia W; Jiang Y
    Front Endocrinol (Lausanne); 2022; 13():882144. PubMed ID: 35784539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation.
    Simsek-Kiper PO; Dikoglu E; Campos-Xavier B; Utine GE; Bonafe L; Unger S; Boduroglu K; Superti-Furga A
    Am J Med Genet A; 2014 Oct; 164A(10):2667-71. PubMed ID: 25099136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease.
    Janssens K; Gershoni-Baruch R; Guañabens N; Migone N; Ralston S; Bonduelle M; Lissens W; Van Maldergem L; Vanhoenacker F; Verbruggen L; Van Hul W
    Nat Genet; 2000 Nov; 26(3):273-5. PubMed ID: 11062463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Camurati-Engelmann disease].
    Kinoshita A
    Nihon Rinsho; 2015 Dec; 73(12):2149-59. PubMed ID: 26666167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease.
    Kinoshita A; Saito T; Tomita H; Makita Y; Yoshida K; Ghadami M; Yamada K; Kondo S; Ikegawa S; Nishimura G; Fukushima Y; Nakagomi T; Saito H; Sugimoto T; Kamegaya M; Hisa K; Murray JC; Taniguchi N; Niikawa N; Yoshiura K
    Nat Genet; 2000 Sep; 26(1):19-20. PubMed ID: 10973241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands.
    Toumba M; Neocleous V; Shammas C; Anastasiadou V; Allgrove J; Phylactou LA; Skordis N
    J Pediatr Endocrinol Metab; 2013; 26(9-10):987-93. PubMed ID: 23729546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-targeted delivery of TGF-β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease.
    Qin Y; Tang S; Zhen G; Ding Q; Ding S; Cao X
    Ann N Y Acad Sci; 2018 Dec; 1433(1):29-40. PubMed ID: 30091466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild Camurati‑Engelamann disease presenting with exophthalmos as the first and only manifestation: A case report.
    Jiajue R; Wu B; Jiang Y; Wang O; Li M; Xing X; Xia W
    Mol Med Rep; 2016 Sep; 14(3):2710-6. PubMed ID: 27484238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease.
    Chen Y; Xie W; Hu F; Chen J; Zheng H; Zhou H; Ni B; Li W; Zhou J
    Mol Med Rep; 2017 Jan; 15(1):235-239. PubMed ID: 27959412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease.
    Campos-Xavier B; Saraiva JM; Savarirayan R; Verloes A; Feingold J; Faivre L; Munnich A; Le Merrer M; Cormier-Daire V
    Hum Genet; 2001 Dec; 109(6):653-8. PubMed ID: 11810278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.